Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parathyroid surgery: separating promise from reality.

Nancy D Perrier1, Philip H G Ituarte, Eugene Morita

  • 1Department of Surgery, University of California, San Francisco/Mount Zion Medical Center, San Francisco, California 94143-1674, USA. nperrier@wfubmc.edu

The Journal of Clinical Endocrinology and Metabolism
|March 13, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-Reported Symptom Burden Among Thyroid Cancer Survivors: Retrospective Cohort Study.

JCO clinical cancer informatics·2026
Same author

Hypoparathyroidism Post Thyroidectomy: Prevention, Evaluation, Management, and Application of Recent Guidelines.

Thyroid : official journal of the American Thyroid Association·2026
Same author

Blood-Based Immunoglobulin-Bound Neoantigen Signatures Associated with MEN Type 1-Related Duodenopancreatic Neuroendocrine Tumor Progression.

Journal of the American College of Surgeons·2026
Same author

The shifting landscape of germline RET pathogenic variants with the introduction of panel testing.

Surgery·2025
Same author

Health Inequity of Stage and Survival of Gastric Cancer in California.

Cancers·2025
Same author

Racial/ethnic disparities in hepatocellular carcinoma treatment and survival: an analysis of the California Cancer Registry.

Cancer treatment and research communications·2025
Same journal

The Extra X Chromosome and Autoimmune Susceptibility in Klinefelter Syndrome.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Pathophysiology-Based Classification of Male Infertility: Evidence from an 800-patient Prospective Cohort.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Parathyroid Carcinoma: From Molecular Pathogenesis to Multidisciplinary Management.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Genetic and Clinical Factors Associated With Metformin Plasma Concentrations Following an Acute Metformin Challenge.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Continuous glucose monitoring-derived time in range is associated with changes in arterial stiffness in type 2 diabetes.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Association of the Primary Aldosteronism Severity Classification with Lateralization and Treatment Outcomes.

The Journal of clinical endocrinology and metabolism·2026
See all related articles

Accurate localization studies are crucial for minimally invasive parathyroidectomy. Sestamibi scans and intraoperative PTH monitoring help select appropriate candidates for this procedure, improving surgical outcomes.

Area of Science:

  • Endocrinology
  • Surgical Oncology
  • Nuclear Medicine

Background:

  • Minimally invasive parathyroidectomy offers advantages but relies on accurate preoperative localization.
  • The efficacy of imaging and biochemical tests in guiding surgical approach for hyperparathyroidism requires further evaluation.

Purpose of the Study:

  • To assess the accuracy of sestamibi scans and intraoperative parathyroid hormone (IOPTH) monitoring in predicting the success of minimally invasive parathyroidectomy.
  • To identify criteria for selecting suitable candidates for minimally invasive parathyroidectomy.

Main Methods:

  • Prospective study involving 71 patients undergoing parathyroidectomy.
  • Preoperative sestamibi scans and intraoperative gamma-probe examinations were performed.
  • Intraoperative PTH (IOPTH) monitoring was utilized to assess parathyroid function.

Related Experiment Videos

Main Results:

  • Sestamibi scans correctly localized solitary adenomas in 95% of primary hyperparathyroidism (HPT) cases but only 25% of multiple adenoma cases.
  • Sestamibi scans showed a single hot spot in 64% of secondary/tertiary disease cases.
  • IOPTH monitoring accuracy was 78% for primary HPT and 45% for nonprimary HPT.
  • A combination of sestamibi scan and IOPTH monitoring correctly guided surgical approach in 93% of selected patients.

Conclusions:

  • Sestamibi scans and IOPTH monitoring are valuable tools for selecting patients for minimally invasive parathyroidectomy.
  • Careful patient selection, excluding familial HPT, secondary/tertiary disease, thyroid pathology, or equivocal scans, is essential.
  • Only 64% of hyperparathyroidism patients meet criteria for a minimally invasive approach, but selected patients have high success rates with combined imaging and IOPTH guidance.